Real-world clinical outcomes in patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US)

2023

Tolaney SM, Punie K, Kurian AW, Ntalla I, Verret W, Sadetsky N, Sjekloca N, Stokes M, Jhaveri KL